Table 1 General characteristics of the study sample
N/Mean | %/SD | |
|---|---|---|
Total Unweighted N | 92,159 | |
Weighted National Estimates | 460,795 | |
Race | ||
White | 351,975 | 76.4 |
Black | 56,920 | 12.4 |
Hispanic | 23,445 | 5.1 |
Asian or Pacific Islander | 16,135 | 3.5 |
Native American | 1,390 | 0.3 |
Others | 10,930 | 2.4 |
Region | ||
Northeast | 102,630 | 22.3 |
Midwest | 103,700 | 22.5 |
South | 185,305 | 40.2 |
West | 69,160 | 15.0 |
Age* | 68.7 | 10.5 |
Sex | ||
Male | 227,935 | 49.5 |
Female | 232,860 | 50.5 |
Median household income | ||
0-25th percentile | 133,765 | 29.0 |
26th to 50th percentile | 121,550 | 26.4 |
51st to 75th percentile | 110,235 | 23.9 |
76th to 100th percentile | 95,245 | 20.7 |
Primary payer | ||
Medicare | 293,600 | 63.7 |
Medicaid | 44,555 | 9.7 |
Private insurance | 99,520 | 21.6 |
Self-pay | 9,735 | 2.1 |
No charge | 845 | 0.2 |
Other | 12,540 | 2.7 |
Severity of Illness | ||
No/Minor comorbidity or complications | 53,735 | 11.7 |
Moderate comorbidity or complications | 156,700 | 34.0 |
Major comorbidity or complications | 176,255 | 38.3 |
Extreme comorbidity or complications | 74,105 | 16.1 |
Surgery | ||
Yes | 108,645 | 23.6 |
No | 352,150 | 76.4 |
Chemotherapy | ||
Yes | 12,370 | 2.7 |
No | 448,425 | 97.3 |
Radiation | ||
Yes | 4,020 | 0.9 |
No | 456,775 | 99.1 |
Hospital Charges [USD]* | 78,010 | 88,588 |
Length of Stay [Days]* | 6.21 | 6.14 |